Bitcoin price and crypto market news
Hyperliquid whale closes BTC and ETH shorts with $1.2M profit
Why it matters: Large Hyperliquid shorts were closed in profit, locking in the whale's gains and potentially easing selling pressure on BTC and ETH.
Fear and Greed Index falls from 69 to 51 in a day
Why it matters: The sharp index drop reflects cooling risk appetite, but the neutral zone does not signal a trend reversal.
STONK falls 16% after $0.35 peak, weekly gain shrinks to 12%
Why it matters: The decline in launchpad activity and volumes points to weakening demand; a loss of $0.15 would open the path to $0.10.
Bitcoin falls to $75,663 after CLARITY Act fails; $677M liquidated
Why it matters: The bill's failure revived regulatory uncertainty; the market is awaiting the FOMC, with $72,000 and a reclaim of the 50-week EMA the key levels for BTC.
CRO drops 4.91% to $0.055 ahead of 1.16B token unlock on September 17
Why it matters: An unlock multiple times the daily trading volume could add further pressure on CRO's price in the coming days.
TRUMP falls 6.41% to $1.87 after CLARITY Act fails in Senate
Why it matters: The CLARITY Act's failure hits political tokens hardest: without a positive regulatory catalyst, a recovery looks unlikely.
ONDO falls 6.63% to $0.328, tests $0.3225 support
Why it matters: Losing the $0.3225 support would open the way to new lows, while holding it could trigger a technical bounce.
Algorand falls 7.77% to $0.088 amid risk-off and CLARITY Act failure
Why it matters: The drop is systemic rather than Algorand-specific: the asset is following the broad risk-off move, with $0.088 the key support level.
Aptos drops 8% to $0.548 after tokenomics change
Why it matters: Higher network costs and lower staking yield reduce APT's appeal to holders and validators.
AERO falls 8.35% to $0.525 after CLARITY Act fails in Senate
Why it matters: Mid-cap DeFi tokens react more sharply to regulatory uncertainty: without federal legislation, the risk for DEX tokens like AERO remains elevated.
VET falls 11.5% to $0.00705 after CLARITY Act failure
Why it matters: The CLARITY Act failure intensified risk-off sentiment in altcoins; VET holds above its 200-day SMA but losing the 7-day SMA signals short-term weakness.
Pi falls 7.53% to $0.0904 on Protocol 27 activation day
Why it matters: Protocol 27 activation failed to hold the price: without a confirmed listing on major exchanges, PI remains a speculative asset under token-unlock pressure.
SPX6900 drops 7% to $0.46 amid CLARITY Act failure and Fed rate expectations
Why it matters: High-beta memecoins are the first to react to the failure of US crypto legislation and the risk of a Fed rate hike.
CRV falls 10.25% to $0.317, tests 38.2% Fibonacci support
Why it matters: Holding the $0.3189 support will preserve CRV's medium-term uptrend; a break below would open the way to the 50-day SMA at $0.2876.
FET falls 11.57% to $0.150, breaks below 50-day SMA
Why it matters: Weakness in high-beta AI-sector tokens amplifies the altcoin selloff as Bitcoin declines and ETF outflows continue.
ICP falls 10.92% to $2.47 after CLARITY Act fails in Senate
Why it matters: ICP's decline is a result of the broad risk-off reaction to the CLARITY Act failure rather than protocol issues; support at $2.42–2.44 remains key.
Filecoin plunges 16.26% to $0.812 after CLARITY Act failure
Why it matters: FIL's decline intensifies the altcoin selloff after the CLARITY Act failure; holding $0.805 will determine whether the asset returns to growth.
INJ Plunges 12% to $5.42 Amid Mass Altcoin Liquidations
Why it matters: INJ's decline reflects broad altcoin weakness after the CLARITY Act failure and a wave of liquidations; holding $5.33 will determine the next move.
SHIB Falls 5.51% to $0.0000049 on Risk-Off and Weak Exchange Flows
Why it matters: Weak flows and burns point to cooling demand; a break below $0.0000048 would open the way to new lows.
AVAX Falls 2.25% to $7.24 Despite KRW1 and UAE Digital ID Adoption
Why it matters: While macro headwinds and uncertainty over the CLARITY Act weigh on the market, Avalanche's fundamental catalysts are not reflected in the price — a delayed re-rating is possible.